Editorial: Viral vector-based gene therapy in neurological disease: The future is now

• Jared B. Smith,
• Laura Cancedda,
• Sergiusz Jozwiak,
• Andrew C. Mercer

Affiliations

Jared B. Smith

Research and Early Development, REGENXBIO Inc., Rockville, MD, United States

Laura Cancedda

Brain Development and Disorders Lab, Istituto Italiano di Tecnologia, Genoa, Italy

Sergiusz Jozwiak

Research Department, The Children's Memorial Health Institute (IPCZD), Warsaw, Poland

Andrew C. Mercer

Research and Early Development, REGENXBIO Inc., Rockville, MD, United States